Advertisement

Topics

What’s Next For CAR T: The Potential of Engineering Immune Cells to Treat Cancer

15:55 EST 13 Nov 2017 | R&D Magazine

Dr. Grupp shares his insights on CAR T-cell therapy’s impact and how researching this type of highly personalized therapy is transforming the industry.
Staff Author: 
Topics: 

Original Article: What’s Next For CAR T: The Potential of Engineering Immune Cells to Treat Cancer

NEXT ARTICLE

More From BioPortfolio on "What’s Next For CAR T: The Potential of Engineering Immune Cells to Treat Cancer"

Advertisement
Quick Search
Advertisement
Advertisement